CalciMedica, Inc. (CALC) Current Ratio
- Current ratio · latest quarter: Value 5.58×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 5.58× | Current assets / current liabilities. $19.46M ÷ $3.49M ≈ 5.58× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 19.46M USD | Assets, Current |
| Current obligations | 3.49M USD | Liabilities, Current |
| Cash and equivalents | 18.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 2.07M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.46M | $3.49M | $18.62M | (m) | (m) | (m) | $2.07M | (m) | 5.58× |
| 2026-03-31 | $8.55M | $5.31M | $8.16M | (m) | (m) | (m) | $1.68M | (m) | 1.61× |
| 2025-12-31 | $13.53M | $3.78M | $11.52M | (m) | (m) | (m) | $1.16M | (m) | 3.58× |
| 2025-09-30 | $14.85M | $3.68M | $5.47M | (m) | (m) | (m) | $1.13M | (m) | 4.04× |
| 2025-06-30 | $18.96M | $3.48M | $5.92M | (m) | (m) | (m) | $1.91M | (m) | 5.45× |
| 2025-03-31 | $25.22M | $4.46M | $12.56M | (m) | (m) | (m) | $2.02M | (m) | 5.66× |
| 2024-12-31 | $19.66M | $3.68M | $7.93M | (m) | (m) | (m) | $2.00M | (m) | 5.34× |
| 2024-09-30 | $15.69M | $3.78M | $9.15M | (m) | (m) | (m) | $1.54M | (m) | 4.15× |
| 2024-06-30 | $20.44M | $3.91M | $5.06M | (m) | (m) | (m) | $2.14M | (m) | 5.22× |
| 2024-03-31 | $26.60M | $4.29M | $6.75M | (m) | (m) | (m) | $1.53M | (m) | 6.21× |
| 2023-12-31 | $11.61M | $4.03M | $5.53M | (m) | (m) | (m) | $1.42M | (m) | 2.88× |
| 2023-09-30 | $15.27M | $3.69M | $11.64M | (m) | (m) | (m) | $1.42M | (m) | 4.14× |
| 2023-06-30 | $20.05M | $4.02M | $19.08M | (m) | (m) | (m) | $1.74M | (m) | 4.98× |
| 2023-03-31 | $34.50M | $12.65M | $24.39M | (m) | (m) | (m) | $2.06M | (m) | 2.73× |
| 2022-12-31 | $1.73M | $4.78M | $1.33M | (m) | (m) | (m) | $2.87M | (m) | 0.36× |
| 2022-09-30 | $45.07M | $3.76M | $10.17M | (m) | (m) | (m) | $498.00K | (m) | 11.98× |
| 2022-06-30 | $51.73M | $4.33M | $13.87M | (m) | (m) | (m) | $1.01M | (m) | 11.95× |
| 2022-03-31 | $58.22M | $4.23M | $8.36M | (m) | (m) | (m) | $541.00K | (m) | 13.77× |
| 2021-12-31 | $67.08M | $4.06M | $13.36M | (m) | (m) | (m) | $527.00K | (m) | 16.53× |
| 2021-09-30 | $74.50M | $4.49M | $11.45M | (m) | (m) | (m) | $2.07M | (m) | 16.59× |
| 2021-06-30 | $76.05M | $4.14M | $7.86M | (m) | (m) | (m) | $2.10M | (m) | 18.37× |
| 2021-03-31 | $88.82M | $6.28M | $10.59M | (m) | (m) | (m) | $1.96M | (m) | 14.15× |
| 2020-12-31 | $99.24M | $7.00M | $33.42M | (m) | (m) | (m) | $2.51M | (m) | 14.18× |
| 2020-09-30 | $95.11M | $7.74M | $94.97M | (m) | (m) | (m) | $4.56M | (m) | 12.29× |
| 2019-12-31 | $36.27M | $12.25M | $15.87M | (m) | (m) | (m) | $4.64M | (m) | 2.96× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |